logo
#

Latest news with #consumer stocks

UBS Trims Colgate (CL) Price Target, Maintains Buy Rating
UBS Trims Colgate (CL) Price Target, Maintains Buy Rating

Yahoo

timea day ago

  • Business
  • Yahoo

UBS Trims Colgate (CL) Price Target, Maintains Buy Rating

Colgate-Palmolive Company (NYSE:CL) is one of the most profitable consumer stocks to buy now. UBS lowered its price target on Colgate-Palmolive (NYSE: CL) to $106 from $109 while maintaining a Buy rating, citing valuation discipline following the stock's steady run in recent months. At the current price of $86.80, the revised target still implies an upside potential of roughly 22%. An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company's oral care products. The firm continues to see strength in Colgate's underlying fundamentals, particularly its strong pricing execution across global markets and steady demand for essential personal care and household products. UBS analysts noted that while foreign exchange and cost headwinds remain part of the equation, margin recovery efforts and disciplined brand investments are likely to support earnings growth through the back half of the year. Colgate has seen consistent performance across its oral care and pet nutrition segments, with emerging markets showing signs of improving volumes. The updated target reflects a more balanced outlook as shares approach levels UBS considers closer to fair value, rather than a change in conviction about the company's prospects. Investors will be watching Colgate's next earnings update for clarity on input cost trends and competitive dynamics, particularly as pricing begins to normalize and volume growth comes back into focus. While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Top 10 Healthcare AI Stocks to Buy According to Hedge Funds and 10 Best Industrial Automation Stocks to Buy for the Next Decade Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Goldman Sachs Raises Philip Morris (PM) Price Target, Maintains Buy Rating
Goldman Sachs Raises Philip Morris (PM) Price Target, Maintains Buy Rating

Yahoo

timea day ago

  • Business
  • Yahoo

Goldman Sachs Raises Philip Morris (PM) Price Target, Maintains Buy Rating

Philip Morris International (NYSE:PM) is one of the most profitable consumer stocks to buy now. Goldman Sachs raised its price target on Philip Morris International (NYSE:PM) to $200 from $190 on July 17, maintaining a Buy rating and signaling confidence in the tobacco giant's earnings trajectory. The new target implies an upside of nearly 12% from the current share price of $178.70. Copyright: jetcityimage / 123RF Stock Photo The upward revision comes ahead of the company's next earnings release, with Goldman pointing to improved operational visibility and strong execution in key international markets. Analysts highlighted the company's ability to navigate shifting regulatory environments while preserving margins through disciplined cost controls and a balanced pricing strategy. Philip Morris has also continued to expand its presence in non-combustible products, though Goldman's update did not place sole emphasis on this segment. Instead, the note referenced broad-based strength in the company's global footprint, where consistent performance in both developed and emerging markets has helped support top-line growth. Investors will be watching closely for commentary on shipment volumes, inventory trends, and guidance updates. With shares hovering near their recent highs, Goldman's call suggests confidence that Philip Morris still has room to move higher as it balances legacy operations with ongoing product innovation. While we acknowledge the potential of PM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Top 10 Healthcare AI Stocks to Buy According to Hedge Funds and 10 Best Industrial Automation Stocks to Buy for the Next Decade Disclosure: None.

Citigroup sets mid-2026 target of 1,150 for MSCI's global equity index
Citigroup sets mid-2026 target of 1,150 for MSCI's global equity index

Free Malaysia Today

time13-07-2025

  • Business
  • Free Malaysia Today

Citigroup sets mid-2026 target of 1,150 for MSCI's global equity index

Citigroup reiterated its 'overweight' view on technology and 'underweight' rating on consumer stocks. (EPA Images pic) NEW YORK : Citigroup introduced its mid-2026 target for the MSCI All Country World Index (ACWI) Local today as they expect global equity markets to be rangebound until year-end, with 'meaningful' gains coming in the first half of next year. The Wall Street brokerage set a target of 1,150 for the benchmark global equity index, implying an upside of about 5% to its last close of 1,100.213. 'Our targets imply the most upside in Japan and Europe over the medium term,' Citi added. The brokerage maintained its preference for European stocks among global equities, but downgraded Japan to 'neutral' on concerns over near-term tariff risks and the strength of the Japanese yen. Global equities have climbed back to all-time highs after a volatile first half of 2025, even as the economic outlook looks uncertain broadly due to Trump's tariffs and geopolitical tensions. Citi set its 2026 year-end earnings-per-share (EPS) growth for the index at above 11%, which remains below consensus estimates of more than 13%. 'Though still positive on average, bottom-up EPS forecasts around the world have been under pressure, as markets grapple with trade tensions and geopolitical uncertainty,' the brokerage said, as it estimated an EPS growth of just above 5% for this year. Citi maintained its 'neutral' stance on US equities and 'underweight' on emerging markets and Australia. On the global sector front, it reiterated its 'overweight' view on technology and 'underweight' rating on consumer stocks.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store